Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Anticancer Agents Med Chem ; 22(10): 1962-1969, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-34477527

RESUMEN

BACKGROUND: Colon cancers are among the top three causes of cancer-related deaths. This study is a continuation of previous research aiming to identify effective treatments. OBJECTIVE: This study investigated the effects of Tarantula cubensis alcoholic extract (TCAE) and Nerium oleander (NO) distillate on the levels of midkine, transforming growth factor (TGF)-ß, vascular endothelial growth factor (VEGF), alpha-fetoprotein (AFP), cyclooxygenase (COX)-2, insulin-like growth factor (IGF) and caspase-3 in the liver and colon tissues of rats with experimentally induced colon cancer. METHODS: The liver and colon tissues of rats were homogeneously divided into control, colon cancer (azoxymethane, AZM), AZM + TCAE, and AZM + NO distillate groups. The levels of midkine, TGF-ß, VEGF, AFP, COX-2, IGF, and caspase-3 in the colon and liver tissues were measured by ELISA. RESULTS: The levels of all parameters in colon and liver tissues in the AZM group were higher (p<0.05) than those in the control group. TCAE and NO distillate prevented (p < 0.05) increases in midkine, TGF-ß, VEGF, AFP, COX-2, IGF, and caspase-3 levels in the colon. NO distillate prevented the increase in all parameters except IGF, whereas TCAE prevented the increase in all values apart from COX-2 and IGF levels in the liver (p<0.05). CONCLUSION: NO distillate and TCAE may prevent the studied markers from reaching specified levels observed in the colon in AZM-induced colon cancer. The increases in the levels of the parameters in the liver were not as severe as those in the colon; however, an 18-week study period may not be sufficient for liver metastasis formation. Future molecular studies should investigate the mechanisms and pathways of these treatments in greater detail.


Asunto(s)
Neoplasias del Colon , Nerium , Arañas , Animales , Productos Biológicos/farmacología , Biomarcadores de Tumor , Caspasa 3 , Neoplasias del Colon/tratamiento farmacológico , Ciclooxigenasa 2 , Hígado , Midkina/farmacología , Nerium/química , Extractos Vegetales/farmacología , Ratas , Arañas/química , Factor de Crecimiento Transformador beta , Factor A de Crecimiento Endotelial Vascular , alfa-Fetoproteínas/farmacología
2.
Acta Vet Hung ; 58(3): 357-67, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20713326

RESUMEN

The aim of this study was to determine the effects of drugs used in the treatment of endotoxaemia on disseminated intravascular coagulation, cytokine levels and adenosine deaminase activities in endotoxaemic rats. Rats were divided into seven groups. Lipopolysaccharide (LPS) was injected into all groups, including the positive control group. The other six groups received the following drugs: enrofloxacin (ENR), flunixin meglumine (FM), low-dose dexamethasone (DEX), high-dose DEX, ENR + FM + low-dose DEX, and ENR + FM + high-dose DEX. After the treatments, serum and plasma samples were collected at 0, 1, 2, 4, 6, 8, 12, 24 and 48 hours (h). A coagulometer was used to determine the levels of coagulation values, while ELISA was used to assay serum cytokines and adenosine deaminase (ADA). Low-dose DEX alone and combined treatments depressed the levels of cytokines and ADA (from 371 to 70 IU/L at 6 h) significantly and inhibited the decrease of coagulation values (antithrombin from 67 to 140% at 6 h, fibrinogen from 54 to 252 mg/dL at 6 h). In summary, FM + high-dose DEX may be the preferred treatment of endotoxaemia because of its highest effectiveness. FM plus high-dose DEX may be a new therapy for endotoxaemic domestic animals.


Asunto(s)
Adenosina Desaminasa/metabolismo , Antibacterianos/uso terapéutico , Antiinflamatorios/uso terapéutico , Citocinas/sangre , Coagulación Intravascular Diseminada/tratamiento farmacológico , Endotoxemia/tratamiento farmacológico , Animales , Clonixina/análogos & derivados , Clonixina/uso terapéutico , Citocinas/metabolismo , Dexametasona/uso terapéutico , Quimioterapia Combinada , Endotoxemia/inducido químicamente , Enrofloxacina , Femenino , Fluoroquinolonas/uso terapéutico , Lipopolisacáridos/toxicidad , Masculino , Ratas , Ratas Sprague-Dawley
3.
Free Radic Res ; 44(4): 397-402, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20102316

RESUMEN

The aim of this study was to determine the effects of enrofloxacin (ENR), flunixin meglumine (FM) and dexamethasone (DEX) on antioxidant status and organ damage markers in experimentally-induced endotoxemia. Rats were divided into three groups. To induce endotoxemia, lipopolysaccharide (LPS) was injected into all groups, including the positive control. The two other groups received the following drugs (simultaneously with LPS): ENR + FM + low-dose DEX and ENR + FM + high-dose DEX. After the treatments, blood samples were collected at 0, 1, 2, 4, 6, 8, 12, 24 and 48 h. Oxidative stress parameters were determined by ELISA, while serum organ damage markers were measured by autoanalyser. LSP increased (p < 0.05) malondialdehyde, 13,14-dihydro-15-keto-prostaglandin F(2 alpha) and nitric oxide, while LPS reduced vitamin C. These changes were especially inhibited (p < 0.05) by ENR + FM + high-dose DEX. LPS increased organ damages markers. Cardiac and hepatic damage was not completely inhibited by any treatment, whereas renal damage was inhibited by two treatments. This study suggested that ENR + FM + high-dose DEX is most effective in the LPS-caused oxidative stress and organ damages.


Asunto(s)
Clonixina/análogos & derivados , Dexametasona/farmacología , Fluoroquinolonas/farmacología , Insuficiencia Multiorgánica/prevención & control , Estrés Oxidativo/efectos de los fármacos , Choque Séptico/tratamiento farmacológico , Animales , Ácido Ascórbico/sangre , Autoanálisis , Biomarcadores/sangre , Clonixina/farmacología , Dinoprost/análogos & derivados , Dinoprost/sangre , Modelos Animales de Enfermedad , Quimioterapia Combinada , Enrofloxacina , Ensayo de Inmunoadsorción Enzimática , Femenino , Cardiopatías/etiología , Cardiopatías/prevención & control , Enfermedades Renales/etiología , Enfermedades Renales/prevención & control , Lipopolisacáridos , Hepatopatías/etiología , Hepatopatías/prevención & control , Masculino , Malondialdehído/sangre , Insuficiencia Multiorgánica/sangre , Insuficiencia Multiorgánica/etiología , Óxido Nítrico/sangre , Ratas , Ratas Sprague-Dawley , Choque Séptico/sangre , Choque Séptico/inducido químicamente , Superóxido Dismutasa/sangre , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA